» Articles » PMID: 39834417

Towards Personalized Cardiometabolic Risk Prediction: A Fusion of Exposome and AI

Overview
Journal Heliyon
Date 2025 Jan 21
PMID 39834417
Authors
Affiliations
Soon will be listed here.
Abstract

The influence of the exposome on major health conditions like cardiovascular disease (CVD) is widely recognized. However, integrating diverse exposome factors into predictive models for personalized health assessments remains a challenge due to the complexity and variability of environmental exposures and lifestyle factors. A machine learning (ML) model designed for predicting CVD risk is introduced in this study, relying on easily accessible exposome factors. This approach is particularly novel as it prioritizes non-clinical, modifiable exposures, making it applicable for broad public health screening and personalized risk assessments. Assessments were conducted using both internal and external validation groups from a multi-center cohort, comprising 3,237 individuals diagnosed with CVD in South Korea within twelve years of their baseline visit, along with an equal number of participants without these conditions as a control group. Examination of 109 exposome variables from participants' baseline visits spanned physical measures, environmental factors, lifestyle choices, mental health events, and early-life factors. For risk prediction, the Random Forest classifier was employed, with performance compared to an integrative ML model using clinical and physical variables. Furthermore, data preprocessing involved normalization and handling of missing values to enhance model accuracy. The model's decision-making process were using an advanced explainability method. Results indicated comparable performance between the exposome-based ML model and the integrative model, achieving AUC of 0.82(+/-)0.01, 0.70(+/-)0.01, and 0.73(+/-)0.01. The study underscores the potential of leveraging exposome data for early intervention strategies. Additionally, exposome factors significant in identifying CVD risk were pinpointed, including daytime naps, completed full-time education, past tobacco smoking, frequency of tiredness/unenthusiasm, and current work status.

References
1.
Tegegne T, Islam S, Maddison R . Effects of lifestyle risk behaviour clustering on cardiovascular disease among UK adults: latent class analysis with distal outcomes. Sci Rep. 2022; 12(1):17349. PMC: 9576714. DOI: 10.1038/s41598-022-22469-6. View

2.
Bonanni A, Basile M, Montone R, Crea F . Impact of the exposome on cardiovascular disease. Eur Heart J Suppl. 2023; 25(Suppl B):B60-B64. PMC: 10120942. DOI: 10.1093/eurheartjsupp/suad069. View

3.
Hahad O, Al-Kindi S, Lelieveld J, Munzel T, Daiber A . Supporting and implementing the beneficial parts of the exposome: The environment can be the problem, but it can also be the solution. Int J Hyg Environ Health. 2023; 255:114290. DOI: 10.1016/j.ijheh.2023.114290. View

4.
Spatz E, Chen K, Krumholz H . Prioritizing the Exposome to Reduce Cardiovascular Disease Burden. JAMA Cardiol. 2023; 9(2):163-164. DOI: 10.1001/jamacardio.2023.4722. View

5.
Montone R, Camilli M, Calvieri C, Magnani G, Bonanni A, Bhatt D . Exposome in ischaemic heart disease: beyond traditional risk factors. Eur Heart J. 2024; 45(6):419-438. PMC: 10849374. DOI: 10.1093/eurheartj/ehae001. View